Position in STTK
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$513,911
-$3,525,240 QoQ
Shares Held
79,924
-92.8% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,114,640,973 across 347 Biotechnology names. STTK ranks #234 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in STTK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $513,911 | 79,924 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $4,039,151 | 1,106,617 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,705,212 | 1,131,888 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $29,216 | 36,891 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $94,812 | 99,803 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $226,376 | 187,089 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $277,796 | 79,598 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $196,805 | 50,986 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $476,492 | 53,299 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $335,423 | 47,044 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $63,909 | 42,046 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $146,184 | 46,854 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $140,452 | 47,773 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $89,051 | 38,718 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $43,442 | 16,090 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $491 | 121 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $35,646 | 8,368 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $181,244 | 21,298 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $381,960 | 18,742 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $285,840 | 9,860 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $527,547 | 18,042 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $409,269 | 7,809 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||